Related Experiment Video
Updated: Aug 9, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Unusual vasovagal-type autonomic dysfunction secondary to immune checkpoint inhibitor therapy
Kelsey Danley1, Mary Jo Fidler2, Aliyah Sadaf3
1Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA kelsey_t_danley@rush.edu.
Abstract:
We present the case of a patient with oral squamous cell carcinoma treated with the programmed death ligand inhibitor, pembrolizumab, an immune checkpoint inhibitor. She subsequently developed vasovagal-type autonomic dysfunction thought to be secondary to the pembrolizumab. The patient's vasovagal symptoms resolved with the initiation of oral glucocorticoids.
More Related Videos
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs Acting on Autonomic Ganglia: Blockers
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis III: Medical Management

